Lupin, Zydus India: Examining the Details
Lupin and Zydus Lifesciences enter a licensing pact to co-market semaglutide injection in India, aiming to improve access to therapies for diabetes and obesity.
Read moreLupin and Zydus Lifesciences enter a licensing pact to co-market semaglutide injection in India, aiming to improve access to therapies for diabetes and obesity.
Read moreFollowing strong fourth quarter results, Elbit CEO Bezhalel Machlis discussed the company’s proactive business strategy at a TASE conference.
Read moreNative Security helps enterprises combat the new threat of AI-based attacks by fully exploiting cloud providers’ existing security tools.
Read moreThe JPC is currently reviewing the Constitution (129th Amendment) Bill, 2024 and the Union Territories Laws (Amendment) Bill, 2024.
Read moreLender secures approvals for ₹4,385 crore investment, with Bain Capital set to acquire stake and become joint promoter alongside existing shareholders.
Read moreA top Sri Lankan official says 32 people have been rescued from a sinking Iranian naval ship off Sri Lanka’s southern coast and have been admitted to a hospital.
Read more5,638 homes were sold last year in Jerusalem and 5,159 in Tel Aviv, the Central Bureau of Statistics reports, as the market recorded a severe slump.
Read morePublic sector workers getting restored benefits under last year’s Social Security Fairness Act would be spared a tax bill on those benefits under new…
Read moreThe deal is reportedly worth $2 billion.
Read more